Pharmabiz1h
Spruce Biosciences announces topline results from CAHmelia-204, CAHptain-205 in adult and paediatric congenital adrenal hyperplasia
Spruce Biosciences, Inc, a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological and endocrine disorders with significant unmet medical need, ...
Pharmabiz3h
FIP releases new skills reference guide focuses on pharmacists supporting self-care for Universal Health Coverage Day
International Pharmaceutical Federation (FIP) has published a ‘Knowledge and skills reference guide for pharmacists supporting self-care’ on Universal Health Coverage Day observed annually on December ...
Pharmabiz4h
Over 1 in 5 adults worldwide has a genital herpes infection – WHO
Around 846 million people aged between 15 and 49 are living with genital herpes infections – more than 1 in 5 of this age-group globally – according to new estimates released. At least 1 person each ...
Pharmabiz5h
Cipher Pharma announces Moberg Pharma’s nail fungus treating product MOB-015 fails to meet primary endpoint in phase 3 study
Cipher Pharma announces Moberg Pharma’s nail fungus treating product MOB-015 fails to meet primary endpoint in phase 3 study: Mississauga Thursday, December 12, 2024, 18:00 Hrs ...
Pharmabiz5h
MannKind and Cipla announce CDSCO approves Afrezza inhalation powder in India
MannKind and Cipla announce CDSCO approves Afrezza inhalation powder in India: Our Bureau, Mumbai Thursday, December 12, 2024, 17:30 Hrs [IST] MannKind Corporation, a company focu ...
Pharmabiz6h
Akoya Biosciences, NeraCare ink license agreement to develop & commercialize Immunoprint test for early-stage melanoma
Akoya Biosciences, NeraCare ink license agreement to develop & commercialize Immunoprint test for early-stage melanoma: Marlborough, Massachusetts Thursday, December 12, 2024, 17: ...
Pharmabiz6h
AGI Greenpac expands global pharmaceutical packaging footprint with new Dubai office
AGI Greenpac expands global pharmaceutical packaging footprint with new Dubai office: Our Bureau, Mumbai Thursday, December ...
Pharmabiz6h
Zeno Health launches 181st medical store, expands its product portfolio
Zeno Health launches 181st medical store, expands its product portfolio: Our Bureau, Mumbai Thursday, December 12, 2024, ...
Pharmabiz7h
NeurAxis receives US FDA 510(k) clearance for RED for testing and evaluation of patients with chronic constipation
NeurAxis receives US FDA 510(k) clearance for RED for testing and evaluation of patients with chronic constipation: Carmel, Indiana Thursday, December 12, 2024, 16:00 Hrs [IST] Ne ...
Pharmabiz7h
Waters highlights continued progress towards sustainability commitments to reduce environmental impact
Waters highlights continued progress towards sustainability commitments to reduce environmental impact: Our Bureau, Bengaluru Thursday, December 12, 2024, 15:40 Hrs [IST] Waters h ...
Pharmabiz7h
AHPI unites corporate healthcare leaders to launch consortium for a TB-Free Uttar Pradesh
AHPI unites corporate healthcare leaders to launch consortium for a TB-Free Uttar Pradesh: Our Bureau, Mumbai Thursday, December 12, 2024, 15:20 Hrs [IST] In a groundbreaking init ...
Pharmabiz8h
NIH study finds tecovirimat was safe but did not improve mpox resolution or pain
NIH study finds tecovirimat was safe but did not improve mpox resolution or pain: Bethesda, Maryland Thursday, December 12, 2024, 15:00 Hrs [IST] The antiviral drug tecovirimat di ...